US 11634482
Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer
granted A61KA61K2039/505A61K39/395
Quick answer
US patent 11634482 (Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer) held by Julius-Maximilians-Universitat Wurzburg expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Julius-Maximilians-Universitat Wurzburg
- Grant date
- Tue Apr 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61K39/395, A61K39/39533, A61K39/3955